2 results
Approved WMOPending
The primary objective is to characterize the change in the Pharmacodynamic (PD) biomarker, fecal calprotectin, during treatment with anrukinzumab.The secondary objectives include:* Characterization of the PK profile and total IL-13 of three multiple…
Approved WMORecruiting
To evaluate the effectiveness of blood pressure (BP) home monitoring on the occurrence of hypertension, efficacy of BP treatment, QOL, health-related symptoms, work ability and life-style behaviour in women 40-60 yrs, after a previous PE in…